PUBLISHER: The Insight Partners | PRODUCT CODE: 1206335
PUBLISHER: The Insight Partners | PRODUCT CODE: 1206335
The Europe hydrocephalus shunts market is expected to grow from US$ 86.26 million in 2022 to US$ 103.40 million by 2028; it is estimated to register a CAGR of 3.1% from 2022 to 2028.
Advancements in Hydrocephalus Valves
Companies in the Europe hydrocephalus shunts market are introducing new advanced programmable valves, shunts based on the latest technologies, and anti-siphon devices, among others. The launch of such advanced programmable valves is propelling the demand for advanced programmable valves.
Market Overview
The Europe hydrocephalus shunts market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Market growth in the region is attributed to the growing geriatric population, a rising prevalence of brain and neurological disorders, and the increasing adoption of advanced programmable valves. Prevalence rates have been estimated between 0.1 and 0.7%, and the incidence rate as 0.015 new cases/1000 per year. Thus, ~3 million people in European countries are suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). An annual burden of EURO 40 billion has been recorded in the European Union (EU).
Europe Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)
Europe Hydrocephalus Shunts Market Segmentation
The Europe hydrocephalus shunts market is segmented into by age group, type, product, end user, and country.
Based on age group, the Europe hydrocephalus shunts market is bifurcated into pediatric and adults. The pediatric segment held the larger market share in 2022.
Based on type, the Europe hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held the largest market share in 2022.
Based on product, the Europe hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment dominated the market share in 2022.
Based on end user, the Europe hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, others. The hospital segment dominated the market share in 2022.
Based on country, the Europe hydrocephalus shunts market is segmented into Germany, the U.K, France, Italy, Spain, and the Rest of Europe. The Germany dominated the market share in 2022.
B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Proteses, inc. ; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the Europe hydrocephalus shunts market.